236 related articles for article (PubMed ID: 20824289)
1. DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.
Toiyama Y; Inoue Y; Yasuda H; Saigusa S; Yokoe T; Okugawa Y; Tanaka K; Miki C; Kusunoki M
J Gastroenterol; 2011 Feb; 46(2):153-63. PubMed ID: 20824289
[TBL] [Abstract][Full Text] [Related]
2. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.
Zhang G; Schetter A; He P; Funamizu N; Gaedcke J; Ghadimi BM; Ried T; Hassan R; Yfantis HG; Lee DH; Lacy C; Maitra A; Hanna N; Alexander HR; Hussain SP
PLoS One; 2012; 7(2):e31507. PubMed ID: 22363658
[TBL] [Abstract][Full Text] [Related]
3. Dehydropeptidase 1 promotes metastasis through regulation of E-cadherin expression in colon cancer.
Park SY; Lee SJ; Cho HJ; Kim TW; Kim JT; Kim JW; Lee CH; Kim BY; Yeom YI; Lim JS; Lee Y; Lee HG
Oncotarget; 2016 Feb; 7(8):9501-12. PubMed ID: 26824987
[TBL] [Abstract][Full Text] [Related]
4. DPEP1 promotes the proliferation of colon cancer cells via the DPEP1/MYC feedback loop regulation.
Liu Q; Deng J; Yang C; Wang Y; Shen Y; Zhang H; Ding Z; Zeng C; Hou Y; Lu W; Jin J
Biochem Biophys Res Commun; 2020 Nov; 532(4):520-527. PubMed ID: 32896379
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer.
Eisenach PA; Soeth E; Röder C; Klöppel G; Tepel J; Kalthoff H; Sipos B
Br J Cancer; 2013 Aug; 109(3):694-703. PubMed ID: 23839495
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological significance of REIC expression in colorectal carcinomas.
Wang W; Zhu W; Xu XY; Nie XC; Yang X; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC
Histol Histopathol; 2012 Jun; 27(6):735-43. PubMed ID: 22473694
[TBL] [Abstract][Full Text] [Related]
7. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
8. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
[TBL] [Abstract][Full Text] [Related]
9. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
[TBL] [Abstract][Full Text] [Related]
10. Aberrant SERCA3 expression during the colorectal adenoma-adenocarcinoma sequence.
Gou WF; Niu ZF; Zhao S; Takano Y; Zheng HC
Oncol Rep; 2014 Jan; 31(1):232-40. PubMed ID: 24213720
[TBL] [Abstract][Full Text] [Related]
11. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
12. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
13. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
14. End-binding protein 1 (EB1) up-regulation is an early event in colorectal carcinogenesis.
Stypula-Cyrus Y; Mutyal NN; Dela Cruz M; Kunte DP; Radosevich AJ; Wali R; Roy HK; Backman V
FEBS Lett; 2014 Mar; 588(5):829-35. PubMed ID: 24492008
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence.
Beitia M; Solano-Iturri JD; Errarte P; Sanz B; Perez I; Etxezarraga MC; Loizate A; Asumendi A; Larrinaga G
Int J Med Sci; 2019; 16(6):813-821. PubMed ID: 31337954
[No Abstract] [Full Text] [Related]
16. Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis.
Giles RH; Lolkema MP; Snijckers CM; Belderbos M; van der Groep P; Mans DA; van Beest M; van Noort M; Goldschmeding R; van Diest PJ; Clevers H; Voest EE
Oncogene; 2006 May; 25(21):3065-70. PubMed ID: 16407833
[TBL] [Abstract][Full Text] [Related]
17. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
Tian X; Yan L; Zhang D; Guan X; Dong B; Zhao M; Hao C
Oncol Rep; 2016 Oct; 36(4):1829-36. PubMed ID: 27499181
[TBL] [Abstract][Full Text] [Related]
18. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
20. Expression of the apoptosis inhibitor livin in colorectal adenoma-carcinoma sequence: correlations with pathology and outcome.
Wang Y; Li Y; Zhou B; Zhang WY; Guan JT; Wang R; Yang L; Xia QJ; Zhou ZG; Sun XF
Tumour Biol; 2014 Dec; 35(12):11791-8. PubMed ID: 25339450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
